Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G de Vries

Showing results (71-80 of 865) with videos related to

Pageof 87
Sort By:
Journal of the Mechanical Behavior of Biomedical Materials|January 28, 2019
Friction in the contact between skin and a soft counter material: Effects of hardness and surface finishM Klaassen, E G de Vries, M A Masen
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
Measurement of agonist and antagonist ligand-binding parameters at the human parathyroid hormone type 1 receptor: evaluation of receptor states and modulation by guanine nucleotideS R Hoare, G de Vries, T B Usdin
Anti-Cancer Drugs|December 1, 1990
Mitoxantrone: bluebeard for malignanciesW T van der Graaf, E G de Vries
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Hepatocellular carcinoma in a patient with Gaucher disease on enzyme supplementation therapyZ Erjavec, C E Hollak, E G de Vries
Seminars in Oncology|December 1, 1994
Chemotherapy dose-escalation with hemopoietic growth factor support in ovarian cancerP H Willemse, H Boonstra, E G de Vries
Journal of the National Cancer Institute|November 20, 1991
Proliferation rate in hereditary nonpolyposis colon cancerA Cats, E G De Vries, J H Kleibeuker
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1993
Antisense of oligonucleotides and the inhibition of oncogene expressionJ Prins, E G de Vries, N H Mulder
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Increased incidence of cardiovascular risk factors in cured testicular cancer patientsJ A Gietema, E G de Vries, D T Sleijfer
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 10, 2011
Pd-NHC catalyzed conjugate addition versus the Mizoroki-Heck reactionAditya L Gottumukkala, Johannes G de Vries, Adriaan J Minnaard
British Journal of Cancer|June 9, 1999
The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospectsG A Hospers, E A Eisenhauer, E G de Vries
Pageof 87

Showing results (71-80 of 865) with videos related to

Sort By:
Pageof 87
Journal of the Mechanical Behavior of Biomedical Materials|January 28, 2019
Friction in the contact between skin and a soft counter material: Effects of hardness and surface finishM Klaassen, E G de Vries, M A Masen
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
Measurement of agonist and antagonist ligand-binding parameters at the human parathyroid hormone type 1 receptor: evaluation of receptor states and modulation by guanine nucleotideS R Hoare, G de Vries, T B Usdin
Anti-Cancer Drugs|December 1, 1990
Mitoxantrone: bluebeard for malignanciesW T van der Graaf, E G de Vries
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Hepatocellular carcinoma in a patient with Gaucher disease on enzyme supplementation therapyZ Erjavec, C E Hollak, E G de Vries
Seminars in Oncology|December 1, 1994
Chemotherapy dose-escalation with hemopoietic growth factor support in ovarian cancerP H Willemse, H Boonstra, E G de Vries
Journal of the National Cancer Institute|November 20, 1991
Proliferation rate in hereditary nonpolyposis colon cancerA Cats, E G De Vries, J H Kleibeuker
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1993
Antisense of oligonucleotides and the inhibition of oncogene expressionJ Prins, E G de Vries, N H Mulder
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Increased incidence of cardiovascular risk factors in cured testicular cancer patientsJ A Gietema, E G de Vries, D T Sleijfer
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 10, 2011
Pd-NHC catalyzed conjugate addition versus the Mizoroki-Heck reactionAditya L Gottumukkala, Johannes G de Vries, Adriaan J Minnaard
British Journal of Cancer|June 9, 1999
The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospectsG A Hospers, E A Eisenhauer, E G de Vries
Pageof 87